Silvia Montoto

13.8k citations

165 papers · 5.2k indexed · h-index 41

Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 127
Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 17
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 42
Oncology top 0.5%
- Viral-associated cancers and disorders 66
- CAR-T cell therapy research 19
Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 37
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 16
Immunology
- T-cell and Retrovirus Studies 14

Co-authors: Francesc Bosch Jude Fitzgibbon Joan Bladé Mohamad Mohty Nicolaus Kröger Rafael F. Duarte Jan Styczyński Mark Bower
Cited by: Pathology and Forensic Medicine Hematology Genetics
Journals: Journal of Clinical Oncology (12 papers)SHILAP Revista de lepidopterología (2 papers)Blood (41 papers)
Partner nations: United Kingdom Spain France

In The Last Decade

Silvia Montoto

157 papers receiving 5.1k citations

Peers

Countries citing papers authored by Silvia Montoto

Since Specialization

Citations

This map shows the geographic impact of Silvia Montoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Montoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Montoto more than expected).

Fields of papers citing papers by Silvia Montoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Montoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Montoto. The network helps show where Silvia Montoto may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Silvia Montoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silvia Montoto Line = papers co-authored together Silvia Montoto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project Blood ·Ranjana H. Advani,Tetiana Skrypets,Monica Civallero,Michael A. Spinner,Martina Manni,Won-Seog Kim,Andrei R. Shustov,Steven M. Horwitz,Felicitas Hitz,María Elena Cabrera,Iván Dlouhy,José Vassallo,Stefano Pileri,Giorgio Inghirami,Silvia Montoto,Umberto Vitolo,John Radford,Julie M. Vose,Massimo Federico	2021	60
2	Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial Bone Marrow Transplantation ·Ruth Pettengell,Rahat Uddin,Ariane Boumendil,Roderick J. Johnson,Bernd Metzner,Alejandro Martı́n,Joanna Romejko‐Jarosińska,Isabelle Bence‐Bruckler,P. Giri,Carsten Utoft Niemann,Stephen Robinson,Eva Kimby,Norbert Schmitz,Peter Dreger,A. H. Goldstone,Silvia Montoto	2021	7
3	How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT Blood Advances ·Olaf Penack,Christophe Peczynski,Mohamad Mohty,Ibrahim Yakoub‐Agha,Jan Styczyński,Silvia Montoto,Rafael F. Duarte,Nicolaus Kröger,Hélène Schoemans,Christian Koenecke,Zinaida Perić,Grzegorz Basak	2020	102
4	Favourable outcomes for high‐risk Burkitt lymphoma patients (IPI 3‐5) treated with rituximab plus CODOX‐M/IVAC: Results of a phase 2 UK NCRI trial SHILAP Revista de lepidopterología ·Elizabeth H. Phillips,Catherine Burton,Amy A. Kirkwood,Sharon Barrans,Anthony Lawrie,Simon Rule,Russell Patmore,Ruth Pettengell,Kirit M. Ardeshna,Silvia Montoto,Shankara Paneesha,Laura Clifton‐Hadley,David C. Linch,Andrew McMillan	2020	6
5	The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy Bone Marrow Transplantation ·(unknown),Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,Bregje Verhoeven,Nicolaus Kröger,Jan Styczyński	2020	122
6	Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy Bone Marrow Transplantation ·Per Ljungman,Małgorzata Mikulska,Rafael de la Cámara,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Harry Dolstra,Arjan C. Lankester,Mohamad Mohty,Silvia Montoto,John Murray,Régis Peffault de Latour,John A. Snowden,Ibrahim Yakoub‐Agha,Bregje Verhoeven,Nicolaus Kröger,Jan Styczyński,(unknown)	2020	11
7	Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas American Journal of Hematology ·Francine M. Foss,Steven M. Horwitz,Monica Civallero,Monica Bellei,Luigi Marcheselli,Won Seog Kim,María Elena Cabrera,Iván Dlouhy,Arnon Nagler,Ranjana H. Advani,Emanuela Anna Pesce,Young Hyeh Ko,Silvia Montoto,Carlos Chiattone,Alison J. Moskowitz,Michele Spina,Marina Cesaretti,Irène Biasoli,Massimo Federico	2019	38
8	Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation Bone Marrow Transplantation ·(unknown),Eva Domingo‐Doménech,Ariane Boumendil,Fina Climent,Gèrard Socié,Frank Kroschinsky,Hervé Finel,E. Vandenbergue,Dan Nemet,Matthias Stelljes,Joerg Thomas Bittenbring,Stephen Robinson,Silvia Montoto,Anna Sureda,Peter Dreger	2019	6
9	The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies Bone Marrow Transplantation ·(unknown),Jakob Passweg,Helen Baldomero,Grzegorz Basak,Christian Chabannon,Selim Corbacioglu,Rafael F. Duarte,Jürgen Kuball,Arjan C. Lankester,Silvia Montoto,Régis Peffault de Latour,John A. Snowden,Jan Styczyński,Ibrahim Yakoub‐Agha,Mutlu Arat,Mohamad Mohty,Nicolaus Kröger	2019	114
10	Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR Cancer ·Anna Sureda,Mei‐Jie Zhang,Peter Dreger,Jeanette Carreras,Timothy S. Fenske,Hervé Finel,Harry C. Schouten,Silvia Montoto,Stephen Robinson,Sonali M. Smith,Ariane Boumedil,Mehdi Hamadani,Marcelo C. Pasquini	2018	40
11	The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project Haematologica ·Monica Bellei,Francine M. Foss,Andrei R. Shustov,Steven M. Horwitz,Luigi Marcheselli,Won Seog Kim,María Elena Cabrera,Iván Dlouhy,Arnon Nagler,Ranjana H. Advani,Emanuela Anna Pesce,Young Hyeh Ko,Virginia Martínez,Silvia Montoto,Carlos Chiattone,Alison J. Moskowitz,Michele Spina,Irène Biasoli,Martina Manni,Massimo Federico	2018	88
12	Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report Bone Marrow Transplantation ·(unknown),Jakob Passweg,Helen Baldomero,Peter Bader,Grzegorz Basak,Chiara Bonini,Rafael F. Duarte,Carlo Dufour,Nicolaus Kröger,Jürgen Kuball,Arjan C. Lankester,Silvia Montoto,Arnon Nagler,John A. Snowden,Jan Styczyński,Mohamad Mohty	2018	101
13	[ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study Journal of Clinical Oncology ·Maurizio Martelli,Luca Ceriani,Emanuele Zucca,Pier Luigi Zinzani,Andrés J.M. Ferreri,Umberto Vitolo,Caterina Stelitano,Ercole Brusamolino,Maria Giuseppina Cabras,Luigi Rigacci,Monica Balzarotti,Flavia Salvi,Silvia Montoto,Armando López‐Guillermo,Erica Finolezzi,Stefano Pileri,Andrew Davies,Franco Cavalli,Luca Giovanella,Peter Johnson	2014	106
14	HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era AIDS ·Rita Coutinho,Alessia Dalla Pria,Shreyans Gandhi,Katharine Bailey,Paul Fields,Kate Cwynarski,Andrew Wilson,Panagiotis Papanastasopoulos,M Tenant‐Flowers,Andrew Webb,Fiona Burns,Robert Marcus,Chloe Orkin,Silvia Montoto,Mark Bower	2013	45
15	Watchful Waiting in Low–Tumor Burden Follicular Lymphoma in the Rituximab Era: Results of an F2-Study Database Journal of Clinical Oncology ·Philippe Solal‐Céligny,Monica Bellei,Luigi Marcheselli,Emanuela Anna Pesce,Stefano Pileri,Peter McLaughlin,Stefano Luminari,Barbara Pro,Silvia Montoto,Andrés J.M. Ferreri,Éric Deconinck,Nöel Milpied,Leo I. Gordon,Massimo Federico	2012	88
16	The role of FDG-PET and bone marrow examination in lymphoma staging Annals of Oncology ·Inas El‐Najjar,Tara Barwick,Norbert Avril,Silvia Montoto	2012	4
17	Follicular lymphoma: managing an indolent malignancy British Journal of Hospital Medicine ·Simon Hallam,Silvia Montoto	2010	0
18	Low dose continuous chemotherapy (LD56): an active treatment with low toxicity for patients with recurrent/refractory lymphoma not eligible for intensive salvage therapy British Journal of Haematology ·Tamara Intermesoli,Jonathan Shamash,A. Z. S. Rohatiner,Andrew Wilson,Andrew Lister,Silvia Montoto	2009	1
19	Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Journal of Clinical Oncology ·Silvia Montoto,Andrew Davies,Janet Matthews,Maria Calaminici,A. J. Norton,John Amess,Sarah Vinnicombe,Rachel Waters,A. Z. S. Rohatiner,T. Andrew Lister	2007	279
20	Successful treatment of isolated cutaneous relapse of follicular lymphoma with rituximab Annals of Hematology ·Ana Ferrer,A. L x F pez-Guillermo,Silvia Montoto,Teresa Estrach,Lluı́s Colomo,E Montserrat	2001	6

About Silvia Montoto

Silvia Montoto is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 165 papers that have together received 5.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (127 papers), Viral-associated cancers and disorders (66 papers), Chronic Lymphocytic Leukemia Research (42 papers), CNS Lymphoma Diagnosis and Treatment (37 papers), CAR-T cell therapy research (19 papers), Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (16 papers) and T-cell and Retrovirus Studies (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.1k citations), Hematology (1.4k citations) and Genetics (1.3k citations). Silvia Montoto has collaborated with scholars based in United Kingdom, Spain and France. Frequent co-authors include Francesc Bosch, Jude Fitzgibbon, Joan Bladé, Mohamad Mohty, Nicolaus Kröger, Rafael F. Duarte, Jan Styczyński, Mark Bower, John A. Snowden and Armando López‐Guillermo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact